Drawing based on the label description. No photo yet.
459 pill
Pill with imprint 459 is white, round, 6 mm and has been identified as Buprenorphine 2 mg. It is supplied by Redpharm Drug, Inc.
Controlled substance: Schedule III
Buprenorphine 2 mg
- Imprint
- 459
- Strength
- 2 mg
- Color
- White
- Shape
- Round
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet
- Manufacturer
- Redpharm Drug, Inc
- NDC
- 67296-1506, 62756-459, 67296-1506-3, 58118-4459, 58118-4459-8, 50268-128, 50268-128-11, 50268-128-15, 62756-459-83, 62756-459-64
Is this your pill? Check every detail
- The imprint reads exactly 459, on the same sides.
- It is white, round, 6 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Buprenorphine Hydrochloride
Inactive: Lactose Monohydrate, Mannitol, Povidone, Unspecified, Anhydrous Citric Acid, Sodium Citrate, Unspecified Form, Butylated Hydroxyanisole, Magnesium Stearate, Starch, Corn
Also distributed by
Clinical Solutions Wholesale, LLC, Avpak, Sun Pharmaceutical Industries, Inc.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
par 256 MINOXIDIL 2 1 2
Minoxidil 2.5 mg
White, round, 7 mm
-
L1
Colchicine Tablets 0.5 Mg 0.5 mg
White, round, 6 mm
-
U 34 2
Lorazepam 2 mg
White, round, 7 mm
Schedule IV
-
Y61
Memantine Hydrochloride 5 mg
White, round, 6 mm
-
25 102 JACOBUS
Dapsone Tablets 25 mg
White, round, 6 mm
-
73 G
Voriconazole 50 mg
White, round, 7 mm
Other Buprenorphine pills
- 153 Buprenorphine 8 mg Orange, oval, 14 mm Schedule III
- 156 Buprenorphine 2 mg Orange, oval, 9 mm Schedule III
- 460 Buprenorphine 8 mg White, round, 10 mm Schedule III
- 54 411 Buprenorphine 8 mg White, round, 10 mm Schedule III
- 54 775 Buprenorphine 2 mg White, round, 13 mm Schedule III
- 798 b Buprenorphine 2 mg White, oval, 10 mm Schedule III
- 799 b Buprenorphine 8 mg White, oval, 14 mm Schedule III
-
RP b2
Buprenorphine 2 mg
White, round, 6 mm
Schedule III